博拓生物: 博拓生物关于完成董事会换届选举及聘任高级管理人员、证券事务代表的公告

Group 1 - The company held its second extraordinary general meeting of shareholders on June 4, 2025, to elect the fourth board of directors, which includes three non-independent directors and three independent directors, along with one employee representative director [1][2] - The newly elected board of directors will serve a term of three years starting from the date of the meeting [1] - Chen Yinlong was elected as the chairman of the fourth board of directors, and various specialized committees were established, including the Strategy Committee, Audit Committee, Nomination Committee, and Compensation and Assessment Committee [2] Group 2 - The company appointed Wu Shujing as the general manager and Chen Yujie, Ye Chunsheng, and Liu Chao as vice general managers, with Fei Qijun appointed as the vice general manager and board secretary, and Yu Miaomiao as the financial officer [3][4] - All appointed senior management personnel meet the qualifications required for their positions and comply with relevant laws and regulations [4][7] - Huang Yufeng was appointed as the securities affairs representative to assist the board secretary [3][4] Group 3 - The third board of directors' independent director Wang Wenming and non-independent director Gao Hongmei will no longer serve after the completion of the board transition [5] - The company will no longer have a supervisory board, and its functions will be assumed by the audit committee of the board of directors [5]